
    
      The study treatment for this protocol is

        -  Loading dose of Cetuximab 400 mg/m2

        -  Weekly Cetuximab 250 mg/m2

        -  Bi-weekly Gemcitabine 50 mg/m2

        -  Daily Radiation for 28 fractions

        -  CT scan four weeks after completion of treatment

        -  Evaluation by surgeon for resectability
    
  